Management Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


MANAGEMENT SCIENCE
Vol. 53, No. 11, November 2007, pp. 1688-1701
DOI: 10.1287/mnsc.1070.0718
This Article
Right arrow Full Text (PDF)
Right arrow e-companion
Right arrow A correction has been published
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venkataraman, S.
Right arrow Articles by Stremersch, S.
Right arrow Search for Related Content

The Debate on Influencing Doctors' Decisions: Are Drug Characteristics the Missing Link?

Sriram Venkataraman, Stefan Stremersch

Goizueta Business School, Emory University, Atlanta, Georgia 30322
School of Economics, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands
Fuqua School of Business, Duke University, Durham, North Carolina 27708

svenka2{at}emory.edu
stefan.stremersch{at}duke.edu

Decision making by physicians on patients' treatment has come under increased public scrutiny. In fact, there is a fair amount of debate on the effects of marketing actions of pharmaceutical firms toward physicians and their impact on physician prescription behavior. While some scholars find a strong and positive influence of marketing actions, some find only moderate effects, and others even find negative effects. Debate is also mounting on the role of other influencers (such as patient requests) in physician decision making, both on prescriptions and sample dispensing. The authors argue that one factor that may tip the balance in this debate is the role of drug characteristics, such as a drug's effectiveness and a drug's side effects.

Using a unique data set, they show that marketing efforts—operationalized as detailing and symposium meetings of firms to physicians—and patient requests do affect physician decision making differentially across brands. Moreover, they find that the responsiveness of physicians' decision making to marketing efforts and patient requests depends upon the drug's effectiveness and side effects. This paper presents clear guidelines for public policy and managerial practice and envisions that the study of the role of drug characteristics, such as effectiveness and side effects, may lead to valuable insights in this surging public debate.

Key Words: physician decision making; marketing effort; patient request; drug effectiveness; side effect; drug prescription; sampling; sample dispensing; detailing; pharmaceuticals; public policy
History: Received: November 9, 2005;





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by INFORMS.